A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
| Status: | Terminated |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any - 17 |
| Updated: | 4/21/2016 |
| Start Date: | September 2011 |
| End Date: | October 2014 |
The purpose of this study is to assess the safety and efficacy of a new formulation of
bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of
paediatric patients with glaucoma.
bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of
paediatric patients with glaucoma.
Inclusion Criteria:
- Diagnosis of congenital, juvenile glaucoma
- Requires treatment with IOP-lowering medication in one or both eyes
Exclusion Criteria:
- Surgical intervention is indicated or planned to lower IOP
- Abnormally low body weight (below 5th percentile)
- Any active eye infection or disease
- Anticipated use of contact lenses during the study
- Topical ocular steroid use within 2 months
- History of ocular trauma in either eye
- Required chronic use of ocular medications (other than study medication) during the
study (intermittent use of artificial tears permitted)
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials